Researchers successfully grafted induced pluripotent stem cell-derived neural precursor cells into the spinal cords of pigs with and without spinal cord injury with only temporary immunosuppression, according to a study in Science Translational Medicine.
The U.S. Department of Justice filed lawsuits to shut down stem cell clinics in Florida and California that marketed unapproved stem cell treatments, the Los Angeles Times reports.
Transplanted human spinal cord-derived neural stem cells may stabilize functioning in amyotrophic lateral sclerosis patients, according to a study in the Annals of Clinical and Translational Neurology.
The global spine biologics market will likely grow at a compound annual growth rate of 4.5 percent between 2018 and 2023, based on a Market.biz report, according to Business News.
Bone Biologics, based in Burlington, Mass., is a publicly traded company focused on orthobiologic solutions.
Luga Podesta, MD, is a sports medicine and regenerative orthopedic specialist at Bluetail Medical Group in Naples, Fla. He was the lead author in a 2013 study in The American Journal of Sports Medicine which demonstrated that platelet-rich plasma can…
The global orthobiologics market is expected to grow from $4.66 billion in 2017 to reach $8.06 billion by 2023, increasing at a 5.7 percent compound annual growth rate, according to a Market.Biz report.
U.K.-based Tissue Regenix Group inked a deal with Premier for TRX's flagship product DermaPure to maintain access to 3,900 hospitals and more than 150,000 healthcare providers in the U.S., according to proactiveinvestors UK.
Biologica Technologies will exhibit clinical data for its ProteiOS growth factor at the American Association of Neurological Surgeons Annual Scientific Meeting in New Orleans.
Medtronic received FDA clearance for a new indication with its Infuse Bone Graft.